Stock 002252 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Shanghai RAAS Blood Products Co., Ltd.

Equities

002252

CNE100000C31

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 02/07/2024 BST 		5-day change 1st Jan Change
7.7 CNY -2.28% Intraday chart for Shanghai RAAS Blood Products Co., Ltd. +1.45% -3.75%
06-20 Haier Gets Regulatory Nod to Buy Controlling Stake in RAAS Blood Products MT
06-19 RAAS Blood Products Renews Cooperation Deal With Spain's Grifols MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haier Gets Regulatory Nod to Buy Controlling Stake in RAAS Blood Products
RAAS Blood Products Renews Cooperation Deal With Spain's Grifols
Haiyingkang Medical Technology Co., Ltd. completed the acquisition of 20% equity stake in Shanghai RAAS Blood Products Co., Ltd. from Grifols, S.A..
Shanghai RAAS Blood Products Co., Ltd. Implements 2023 Final Profit Distribution Plan of A Shares, Payable on 05 June 2024
Shanghai Raas Blood Products Co., Ltd. Approves 2023 Profit Distribution Plan
GRIFOLS CEO SAYS CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLO…
Point marchés-L'Europe clôture en hausse, l'économie de la zone euro montre des signes d'amélioration
Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth
Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Grifols to refinance debt due in 2025 via sales of notes, Shanghai RAAS stake
RAAS Blood Products Gets Regulatory Nod to Trial Drug for Bleeding Disorders
Grifols dice se ha cumplido la debida diligencia en la venta de la participación en Shanghai RAAS 
Actualización de las fuertes variaciones del día: Drax y UMG seducen, mientras que Amadeus y Grifols decepcionan
Grifols' shares tumble as restructuring costs hit annual profit
Grifols dice que está en vías de reducir su ratio de deuda
Les actions en mouvement : Euroapi, Nexity, AMS-Osram ... des beaux cartons aujourd'hui
S&P Maintains Grifols' Rating, Stable Outlook Amid Expected Deleveraging
La BCE starebbe sondando con discrezione le banche creditrici di Grifols
S&P keeps Grifols at 'B+', sees leverage decreasing in 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002252 Stock
  4. News Shanghai RAAS Blood Products Co., Ltd.
  5. Other languages